Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 36 of 6351
-
Brain chip breakthrough: paralysis patients may control devices with thought
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the brain to allow adults affected by disabling paralysis (see Eligibility for more details) to control and receive feedback …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New antibody drug aims to outsmart Treatment-Resistant myeloma
Disease control Not yet recruitingThe goal of this Phase 2 clinical trial is to learn whether YKST02 is effective and safe in adults with relapsed or refractory multiple myeloma. The study will also evaluate how YKST02 is processed by the body (pharmacokinetics), how it affects the body (pharmacodynamics), and wh…
Phase 2 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Scientists hunt for biomarkers to catch pancreatic cancer before it strikes
Diagnosis Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) is one of the cancers with the poorest prognosis and is often diagnosed at an advanced stage, resulting in very low 5-year survival rates. Many PDACs arise from non-invasive precursor lesions that develop over years, including pancreatic in…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Blood filter could shield vessels in septic shock
Disease control Not yet recruitingThis study aims to investigate the effects of adjunctive CytoSorb hemoadsorption therapy versus standard medical treatment on endothelial dysfunction in patients with refractory septic shock. The investigators hypothesize that hemoadsorption mitigates endothelial and glycocalyx i…
Sponsor: Semmelweis University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
A pill to stop the bleeding? new hope for HHT nosebleeds
Disease control Not yet recruitingThe primary objective of this trial is to assess the efficacy of engasertib 40 mg once daily (QD) in reducing the frequency of epistaxis compared to placebo QD during 28 weeks of double-blind treatment in participants with moderate to severe HHT.
Phase 3 • Sponsor: Vaderis Therapeutics AG • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a blood pressure cuff shield the brain after a severe stroke?
Disease control Not yet recruitingAneurysmal subarachnoid hemorrhage (SAH) is a severe form of stroke caused by bleeding around the brain. Despite early treatment of the initial hemorrhage, many patients develop delayed cerebral ischemia several days later, which is a major cause of neurological disability, cogni…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
Disease control Not yet recruitingThis study is a randomized clinical trial evaluating a focused ultrasound treatment for people with advanced Parkinson's disease (PD) who have disabling motor complications and symptoms. The study uses the Exablate Neuro System, which delivers MR-guided Focused Ultrasound (MRgFU…
Sponsor: InSightec • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
A spoonful of milk a day: could it rewire Kids' allergies?
Disease control Not yet recruitingThis clinical trial aims to investigate if oral immunotherapy can help children with cow's milk allergy tolerate cow's milk. Children aged 6-18 months can take part in the trial. Main question: What percentage of children can tolerate cow's milk after oral immunotherapy, compar…
Sponsor: Laura Ozer Kettner • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can head position and cooling boost brain recovery after cardiac arrest?
Disease control Not yet recruitingThe goal of this platform clinical trial is to evaluate whether specific post-cardiac arrest care strategies can improve neurological recovery and survival in adult patients who remain comatose after return of spontaneous circulation (ROSC) following cardiac arrest and require in…
Sponsor: Kagawa University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can an Anti-Inflammatory drug make liver cancer immunotherapy safer?
Disease control Not yet recruitingThis is a Phase 2, open-label, single-arm, multicenter study designed to evaluate the safety and efficacy of atezolizumab, bevacizumab, and tocilizumab in patients with locally advanced, metastatic, and/or unresectable hepatocellular carcinoma (HCC). Approximately 51 patients wil…
Phase 2 • Sponsor: CHA University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a common steroid tame severe flu in the ICU?
Disease control Not yet recruitingThis is a Phase III, multicentre, randomized, controlled, double-blind, superiority trial aiming to evaluate the efficacy of dexamethasone versus placebo in patients admitted to intensive care or intermediate care with influenza and hypoxemic acute respiratory failure. Patients w…
Phase 3 • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a Two-Drug combo outsmart Hard-to-Treat breast cancer?
Disease control Not yet recruitingThis is a multicenter, open-label, single-arm phase II clinical trial designed to evaluate the efficacy and safety of Sacituzumab govitecan (SG) in combination with Q901 in patients with advanced (metastatic/recurrent/unresectable) triple-negative breast cancer (TNBC) whose disea…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A deeper genetic look at fetuses with ultrasound warning signs
Diagnosis Not yet recruitingPrenatal exome sequencing (ES) is increasingly used for fetuses with ultrasound-detected anomalies but yields 10-15% variants of uncertain significance (VUS), limiting diagnostic performance, particularly in prenatal settings with incomplete phenotypes. This study aims to evalua…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Beta-Blocker may rewrite traumatic memories in PTSD
Disease control Not yet recruitingPost-traumatic stress disorder (PTSD) develops after life-threatening events, with domestic violence and sexual assault being major risk factors. An innovative approach using traumatic memory reactivation with propranolol has shown promise in reducing PTSD symptoms. This study ai…
Phase 3 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Sleep patterns in coma may reveal who will wake up
Knowledge-focused Not yet recruitingSevere brain injuries can leave people in states where they are unconscious or only partly aware, such as a coma. These conditions are common after injuries like head trauma or bleeding in the brain. One of the biggest challenges for doctors is knowing if - or when - a patient wi…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Laser and AI team up to spot lung cancer in minutes
Diagnosis Not yet recruitingTo investigate the diagnostic efficacy of Femtosecond Laser Label-Free Imaging combined with artificial intelligence-assisted diagnosis for rapid diagnosis of lung cancer.
Sponsor: Shanghai Zhongshan Hospital • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a targeted drug outperform chemotherapy for stomach cancer?
Disease control Not yet recruitingThis is a randomized, controlled, open-label, multicenter Phase III study to evaluate the efficacy and safety of ATG-022 compared with Investigator's Choice in participants with CLDN18.2-positive advanced gastric or gastroesophageal junction adenocarcinoma.
Phase 3 • Sponsor: Antengene Biologics Limited • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a weekly shot ease sleep apnea and shed weight?
Disease control Not yet recruitingThis is a 56-week randomized, double blinded, parallel-controlled study evaluating the efficacy and safety of the HDM1005 in patients with obstructive sleep apnea (OSA) and obesity receiving positive airway pressure (PAP) therapy. Eligible participants will be screened and random…
Phase 3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a drug combo replace chemo before breast cancer surgery?
Disease control Not yet recruitingThis is a single-arm, prospective, multicenter, phase II clinical study evaluating the efficacy and safety of a chemotherapy-free neoadjuvant regimen in patients with HR-positive/HER2-positive (HR+/HER2+) early or locally advanced breast cancer. Approximately 33 treatment-naive …
Phase 2 • Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a pill combo keep uveal melanoma from coming back?
Disease control Recruiting nowThis is a randomized, multi-center, open-label study of adjuvant darovasertib in participants with non-metastatic uveal melanoma (OptimUM-11)
Phase 3 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC